Japan, Jan. 23 -- GILEAD SCIENCES INC has got intellectual property rights for 'METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH GP120 V3 GLYCAN-DIRECTED ANTIBODIES.' Other related details are as follows:

Application Number: JP,2024-091552

Category (FI): A61K39/395@N,A61K31/437,C12Q1/6869@Z,C12Q1/02,C07K19/00,A61P43/00,121,C07K16/10,C07K14/16,A61K39/395@S,A61P31/18,A61K39/395@D,A61K31/519

Stage: Grant (IP right document published.)

Filing Date: June 5, 2024

Publication Date: Aug. 21, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....